Featured Research

from universities, journals, and other organizations

Thyroid cancer cells become less aggressive in outer space

Date:
January 30, 2014
Source:
Federation of American Societies for Experimental Biology
Summary:
For those who think that space exploration offers no tangible benefits, new research involving thyroid cancer may prove otherwise. Researchers show that some tumors which are aggressive on earth are considerably less aggressive in microgravity. By understanding the genetic and cellular processes that occur in space, scientists may be able to develop treatments that accomplish the same thing on Earth.

Three-dimensional, multicellular tumor spheroids begin to form after exposure to real microgravity.
Credit: Team Daniela Grimm

For those who think that space exploration offers no tangible benefits for those of us on earth, a new research discovery involving thyroid cancer may prove otherwise. In a new report appearing in the February 2014 issue of The FASEB Journal, researchers from Germany and Denmark show that some tumors which are aggressive on earth are considerably less aggressive in microgravity. By understanding the genetic and cellular processes that occur in space, scientists may be able to develop treatments that accomplish the same thing on earth.

"Research in space or under simulated microgravity using ground-based facilities helps us in many ways to understand the complex processes of life and this study is the first step toward the understanding of the mechanisms of cancer growth inhibition in microgravity," said Daniela Gabriele Grimm, M.D., a researcher involved in the work from the Department of Biomedicine, Pharmacology at Aarhus University in Aarhus, Denmark. "Ultimately, we hope to find new cellular targets, leading to the development of new anti-cancer drugs which might help to treat those tumors that prove to be non-responsive to the currently employed agents."

To make their discovery, Grimm and colleagues used the Science in Microgravity Box (SIMBOX) experimental facility aboard Shenzhou-8, which was launched on October 31, 2011. Cell feeding was automatically performed in space on day five and automated cell fixation was conducted on day 10. Inflight control was achieved by using a centrifuge in space. On November 17, 2011, Shenzhou-8 landed and the experimental samples were analyzed. Additional cells were analyzed using a random positioning machine which aims to achieve simulated microgravity conditions on the ground by rotating a sample around two axes operated in a random real direction mode. Both cell types were investigated with respect to their gene expression and secretion profiles, employing modern molecular biological techniques, such as whole genome microarrays and multi-analyte profiling. Results suggested that the expression of genes indicating a high malignancy in cancer cells may be down-regulated under altered gravitational stimulation.

"We are just at the beginning of a new field of medicine that studies the effects of microgravity on cell and molecular pathology. Space flight affects our bodies, both for good and bad," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "We've known that microgravity can cause some microorganisms to become more virulent and that prolonged microgravity has negative effects on the human body. Now, we learn that it's not all bad news: what we learn from cells in space should help us understand and treat malignant tumors on the ground."


Story Source:

The above story is based on materials provided by Federation of American Societies for Experimental Biology. Note: Materials may be edited for content and length.


Journal Reference:

  1. X. Ma, J. Pietsch, M. Wehland, H. Schulz, K. Saar, N. Hubner, J. Bauer, M. Braun, A. Schwarzwalder, J. Segerer, M. Birlem, A. Horn, R. Hemmersbach, K. Wasser, J. Grosse, M. Infanger, D. Grimm. Differential gene expression profile and altered cytokine secretion of thyroid cancer cells in space. The FASEB Journal, 2013; 28 (2): 813 DOI: 10.1096/fj.13-243287

Cite This Page:

Federation of American Societies for Experimental Biology. "Thyroid cancer cells become less aggressive in outer space." ScienceDaily. ScienceDaily, 30 January 2014. <www.sciencedaily.com/releases/2014/01/140130102038.htm>.
Federation of American Societies for Experimental Biology. (2014, January 30). Thyroid cancer cells become less aggressive in outer space. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/01/140130102038.htm
Federation of American Societies for Experimental Biology. "Thyroid cancer cells become less aggressive in outer space." ScienceDaily. www.sciencedaily.com/releases/2014/01/140130102038.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

More Coverage


Some Tumors Much Less Aggressive in Space Than on Earth

Feb. 28, 2014 Some tumors seem to be much less aggressive in space compared to their behavior on Earth, which could help scientists understand the mechanism involved and develop drugs targeting tumors that ... read more
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins